NANOGENIC SOLUTIONS

nanogenic-solutions-logo

Nanogenic Solutions operates as a company developing the artificial virus, a new kind of vector for gene therapy. Nanogenic Solutions have committed to overcoming the obstacle of delivery to fulfil the promise of gene therapy, working alongside innovative partners to bring cutting-edge treatments to market. Nanogenics is developing LipTide, an artificial virus, which acts as a custom-built delivery system that can be modified to target different cell types and deliver different payloads, making the promise of gene therapy one step closer to reality. LipTide is a protein based nanoparticle, which mimics natural viruses, but by-passes the many problems of viral delivery. The ability to regularly dose gene therapy payloads with LipTide could revolutionise the approach to gene therapy

#Website #More

NANOGENIC SOLUTIONS

Social Links:

Industry:
Biotechnology Health Care Medical Pharmaceutical

Address:
Selkirk, Scottish Borders, The, United Kingdom

Country:
United Kingdom

Website Url:
http://www.nanogenics.co.uk

Status:
Active

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Font Awesome Mobile Non Scaleable Content Nginx Amazon


Official Site Inspections

http://www.nanogenics.co.uk

  • Host name: ip82-165-196-100.pbiaas.com
  • IP address: 82.165.196.100
  • Location: Germany
  • Latitude: 51.2993
  • Longitude: 9.491
  • Timezone: Europe/Berlin

Loading ...

More informations about "Nanogenic Solutions"

Nanogenics - Delivering Gene Therapy

NanoGenics is a leading RNA therapeutics company. We are committed to developing cutting โ€ฆSee details»

Our Team - Nanogenics

Our unique team of experts brings together experience, passion and expertise. Suzy is an โ€ฆSee details»

NanoGenics - LinkedIn

Nanogenics is an innovative, research-based biotechnology company that specialises in โ€ฆSee details»

NanoGenics Ltd - VentureRadar

Website: http://www.nanogenics.co.uk Develops innovative siRNA therapeutics for cancer and โ€ฆSee details»

NANOGENICS LIMITED overview - Find and update company โ€ฆ

NANOGENICS LIMITED - Free company information from Companies House including โ€ฆSee details»

Nanogenics - Crunchbase Company Profile & Funding

Nanogenics Ltd is a research-based biotechnology company, engages in the development of โ€ฆSee details»

Nanogenic Solutions - Crunchbase Company Profile & Funding

Nanogenic Solutions operates as a company developing the artificial virus, a new kind of vector โ€ฆSee details»

Nanogenics - Products, Competitors, Financials, Employees, โ€ฆ

Nanogenics focuses on the Ribonucleic Acid (RNA) therapeutics domain, focusing on the โ€ฆSee details»

NanoGenics Ltd. - CMOCRO

NanoGenics Ltd. is a leading siRNA therapeutics company looking to address major unmet โ€ฆSee details»

Contact Us - Nanogenics

[email protected] Our mission is to revolutionise the treatment fibrotic diseases โ€ฆSee details»

Acquisition of Nanogenics Ltd - N4 Pharma

Sep 29, 2023ย ยท N4 Pharma is pleased to announce the acquisition of a controlling interest, โ€ฆSee details»

University spin outs: a rich source of innovation and ... - FICPI

Https://nanogenics.co.uk/en/ โ€œIn the case of NanoGenics, the researchers had demonstrated โ€ฆSee details»

Biotech acquisition - RYBOQUIN acquires NanoGenics - etsc.co.uk

The Scottish Biotech company Ryboquin, announces the acquisition of Nanogenic Solutions, to โ€ฆSee details»

WHAT WE DO - Nanogenics

NanoGenics is a leading RNA therapeutics company looking to address major unmet need in โ€ฆSee details»

Nanogenics Company Profile - Office Locations, Competitors, โ€ฆ

Nanogenics is a company developing an artificial virus for gene therapy. Its product ECP-102 โ€ฆSee details»

Delivering Gene Therapy - Nanogenics

NanoGenics is a leading RNA therapeutics company. We are committed to developing cutting โ€ฆSee details»

Nanogenics - N4 Pharma

N4 Pharma has a controlling interest in Nanogenics Limited. Nanogenics has developed a lipid โ€ฆSee details»

Our Delivery - Nanogenics

Optimised delivery of siRNA payloads.See details»

ECP 105 - AdisInsight - Springer

Aug 9, 2023ย ยท ECP 105, carrying myocardin-related transcription factor (MRTF-B) siRNA is โ€ฆSee details»

Our Products - nanogenics.co.uk

We have ongoing programmes to bring our own RNA medicines to the clinic. We are actively โ€ฆSee details»